Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 16, 2016
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Award
Common Stock, no par value
2016-05-12+84,975→ 534,525 total
Footnotes (2)
- [F1]Represents Restricted Share Units("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]One-third (1/3) of the RSUs will vest six months from the date of grant, one-third (1/3) of the RSUs will vest twelve months from the date of grant and one-third (1/3) of the RSUs will vest eighteen months from the date of grant, subject to continued employment through each vesting date.